Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scaling HIV self-testing to improve health equity among cisgender gay, bisexual and other men who have sex with men, trans and gender-diverse people in the United Kingdom: An HIV self-testing implementation action framework.

HIV medicine·2026
Same author

Belief in the 'Undetectable equals Untransmissible'(U=U) statement and associations with stigma, mental health and sexual satisfaction in people living with HIV (PWH) in the UK.

AIDS (London, England)·2026
Same author

Late HIV diagnosis and subsequent time to antiretroviral initiation and viral suppression in a large London HIV centre.

HIV medicine·2026
Same author

Living <i>hi</i>: GBMSM narratives of pleasure, risk, and everyday <i>hi-fun</i> (chemsex) navigation in Thailand.

medRxiv : the preprint server for health sciences·2026
Same author

Service needs of people living with HIV in the UK (Positive Voices 2022): a cross-sectional survey.

The lancet. HIV·2026
Same author

Hi-fun, homepas and incidental sex with drugs: a qualitative study developing a locally grounded definition of hi-fun (chemsex) compared to other sexualised drug use types practiced by gay, bisexual and other men who have sex with men in Thailand.

Harm reduction journal·2026

Related Experiment Video

Updated: Jun 23, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

HIV as a chronic disease.

Tabitha W Mahungu1, Alison J Rodger, Margaret A Johnson

  • 1Department of HIV Medicine, Royal Free NHS Trust, London. wambura@gmail.com

Clinical Medicine (London, England)
|May 14, 2009
PubMed
Summary
This summary is machine-generated.

Highly active antiretroviral therapy (HAART) transformed HIV treatment, but challenges like long-term effects and rising global cases persist. A united global approach is crucial to combat the ongoing HIV/AIDS epidemic.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Experiment Videos

Last Updated: Jun 23, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Area of Science:

  • Infectious Diseases
  • Public Health
  • Virology

Background:

  • 2006 marked significant anniversaries for AIDS and HAART, highlighting treatment progress.
  • HAART has revolutionized HIV management where accessible.
  • Despite advances, HIV remains a growing concern in vulnerable, under-resourced regions.

Purpose of the Study:

  • To reflect on milestones in HIV/AIDS treatment and management.
  • To identify persistent challenges in the era of HAART.
  • To emphasize the need for global collaboration in combating the HIV epidemic.

Main Methods:

  • Review of historical data and treatment advancements.
  • Analysis of current HIV/AIDS trends and challenges.
  • Discussion of future strategies for epidemic control.

Main Results:

  • HAART has significantly improved outcomes for treated HIV patients.
  • Long-term effects, drug resistance, and patient aging present new challenges.
  • HIV cases continue to increase in vulnerable global populations.

Conclusions:

  • While HAART is a major success, it has introduced new complexities.
  • The global HIV epidemic requires sustained and collaborative efforts for containment.
  • Addressing disparities in under-resourced areas is critical for future progress.